Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 March 2007

Ann Rheum Dis. Published Online First: 17 October 2006. doi:10.1136/ard.2006.062091
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text (Rapid PDF)
Right arrow web only appendix
Right arrow All Versions of this Article:
ard.2006.062091v1
66/3/377    most recent
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, W
Right arrow Articles by Zimmermann-Górska, I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, W
Right arrow Articles by Zimmermann-Górska, I

Extended Report

Eular evidence based recommendations for the management of hand osteoarthritis - report of a task force of the Eular Standing Committee for International Clinical Studies Including Therapeutics(ESCISIT)

W Zhang 1*, M Doherty 1, B F Leeb 2, L Alekseeva 3, N K Arden 4, J W Bijlsma 5, F Dincer 6, K Dziedzic 7, H J Häuselmann 8, G Herrero-Beaumont 9, P Kaklamanis 10, S Lohmander 11, E Maheu 12, E Martín-Mola 13, K Pavelka 14, L Punzi 15, S Reiter 16, J Sautner 17, J Smolen 18, G Verbruggen 19 and I Zimmermann-Górska 20

1 Nottingham University, United Kingdom
2 2 nd Dept. of Medicine Lower Austrian Center of Rheumatology, Austria
3 Russian Academic Medical School, Russian Federation
4 Southampton General Hospital, United Kingdom
5 Rheumatology and Clinical Immunology Department, University Medical Center Utrecht, Netherlands
6 Hacettepe University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Turkey
7 Primary Care Musculoskeletal Research Centre, Keele University, Keele, United Kingdom
8 Clinic Im Park Hirslanden Group, Centre for Rheumatology and Bone Disease, Zurich, Switzerland
9 Servicio de Reumatologia, Fundacion Jimenez Diaz, Madrid, Spain
10 16, Anaperon Polemou St, Athens, Greece
11 Lund University, Sweden
12 Rheumatology, Hospital Saint-Antoine, Paris, France
13 Servicio de Reumatologia, Hospital Universitario La Paz, Madrid, Spain
14 Institute of Rheumatology, Na Slupi 4, Prague, Czech Republic
15 Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Padova, Italy
16 Rheumatology Unit, Federal Institute for Drugs and Medical Devices, Bonn, Germany
17 2nd Department of Medicine, Lower Austrian Center for Rheumatology, Stockerau, Austria
18 Department of Medicine, Krankenhauz Lainz, Vienna, Austria
19 Department of Rheumatology, Ghent University Hospital, Gent, Belgium
20 Department of Rheumatology, Rehabilitation and Internal Medicine, University of Medical Sciences, Po, Poland

* To whom correspondence should be addressed. E-mail: weiya.zhang{at}nottingham.ac.uk.

Accepted 10 October 2006


*  Abstract

Objectives: To develop evidence based recommendations for the management of hand osteoarthritis (OA).

Methods: The multidisciplinary guideline development group comprised 16 rheumatologists, 1 physiatrist, 1 orthopaedic surgeon, 2 allied health professionals and 1 evidence based medicine expert, representing 15 different European countries. Each participant contributed up to 10 propositions describing key clinical points regarding management of hand OA. Final recommendations were agreed using a Delphi consensus approach. A systematic search of MEDLINE, EMBASE, CINAHL, Science Citation Index, AMED, Cochrane Library, HTA and NICE reports was used to identify the best available research evidence to support each of the propositions. Where possible the effect size and number needed to treat were calculated for efficacy. Relative risk or odds ratio was estimated for safety and incremental cost-effectiveness ratio was used for cost- effectiveness. The strength of recommendation was provided according to research evidence, clinical expertise and perceived patient preference.

Results: Eleven key propositions involving 17 treatment modalities were generated through three Delphi rounds. Treatment topics included general considerations (eg, clinical features, risk factors, co-morbidities), non-pharmacological (eg, education plus exercise, local heat and splint), pharmacological (eg, paracetamol, NSAIDs, NSAIDs plus gastroprotective agents, COX-2 inhibitors, systemic slow acting disease-modifying drugs, intra-articular corticosteroid) and surgery. Of 17 treatment modalities, only 6 were supported by research evidence (education plus exercise, NSAIDs, COX- 2 inhibitors, topical NSAIDs, topical capsaicin and chondroitin sulphate). Others were supported either by evidence extrapolated from studies of OA affecting other joint sites or by expert opinion. Strength of recommendation varied according to level of evidence, benefits and harms/costs of the treatment and clinical expertise.

Conclusion: Eleven key recommendations for treatment of hand OA were developed using a combination of research-based evidence and expert consensus. The evidence was evaluated and the strength of recommendation was provided.


Keywords: EULAR, hand osteoarthritis, treatment guidelines




This article has been cited by other articles:


Home page
Ann Rheum DisHome page
T K Kvien, E Fjeld, B Slatkowsky-Christensen, M Nichols, Y Zhang, A Proven, K Mikkelsen, O Palm, A A Borisy, and J Lessem
Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis
Ann Rheum Dis, July 1, 2008; 67(7): 942 - 948.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
H I Keen, F Lavie, R J Wakefield, M-A D'Agostino, H B. Hammer, E Hensor, A Pendleton, D Kane, H Guerini, C Schueller-Weidekamm, et al.
The development of a preliminary ultrasonographic scoring system for features of hand osteoarthritis
Ann Rheum Dis, May 1, 2008; 67(5): 651 - 655.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J N Hoes, J W G Jacobs, M Boers, D Boumpas, F Buttgereit, N Caeyers, E H Choy, M Cutolo, J A P Da Silva, G Esselens, et al.
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
Ann Rheum Dis, December 1, 2007; 66(12): 1560 - 1567.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

About the fourth EULAR recommendation for hand osteoarthritis.
Romain J Forestier, et al.
Ann Rheum Dis Online, 22 Mar 2007 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism